Fairvalue-Calculator Fairvalue-Calculator
EN DE

CoreCivic, Inc (CXW) Fair Value & Analysis

Industrials · US · Market cap $2.3B

Price$29.73
Fair Value$18.88
Upside-36.5%
Quality95/100
Evidence: High Range $11.99 – $41.07

Analysis

CoreCivic, Inc (CXW) currently trades at $29.73, while our model-based Fair Value estimate is $18.88 — implying the stock looks roughly 36.5% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

CoreCivic, Inc. owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides a range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address recidivism crisis, and government real estate solutions. Its correctional, detention, and residential reentry facilities offer rehabilitation and educational programs, including basic education, faith-based services, life skills and employment training, and substance abuse treatment; food services; and work and recreational programs as well as health care services, including medical, dental, and mental health services. The company was founded in 1983 and is based in Brentwood, Tennessee.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.